Marc A. Began - Mar 20, 2023 Form 3 Insider Report for Axogen, Inc. (AXGN)

Role
EVP & General Counsel
Signature
Marc Began
Stock symbol
AXGN
Transactions as of
Mar 20, 2023
Transactions value $
$0
Form type
3
Date filed
3/30/2023, 04:39 PM
Previous filing
Dec 27, 2022
Next filing
Feb 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXGN Restricted Stock Units Mar 20, 2023 Common Stock 45K $0.00 Direct F1
holding AXGN Employee Stock Option (right to purchase) Mar 20, 2023 Common Stock 90K $8.16 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 1, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.